HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) saw a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 23,200 shares, a drop of 13.4% from the July 15th total of 26,800 shares. Approximately 0.1% of the company’s shares are short sold. Based on an […]
Related Keywords
Rebecca Byam , Biologics Company Profile , Nasdaq , Biologics Inc , Vanguard Group Inc , Ef Hutton Acquisition Co , Hcw Biologics Inc , Blackrock Inc , Hightower Advisors , Securities Exchange Commission , Get Free Report , Stock Down , Exchange Commission , Tower Advisors , Hcw Biologics , Nasdaq Hcwb , Hcwb , Medical , Stocks , Options , Put , Call ,
vimarsana.com © 2020. All Rights Reserved.